Ming Yuan, Wei Hongmei, Zhang Yulin, Gao Guoqiang, Deng Bo, Huang Li, Wang Qiuping, Zheng Xiaodan, Luo Xue
Department of Ultrasound, The First People's Hospital of Longquanyi District, Chengdu, China.
Department of Otolaryngology-Head and Neck, The First People's Hospital of Longquanyi District, Chengdu, China.
Curr Med Imaging. 2024 Mar 7. doi: 10.2174/0115734056261616231224161652.
Pyogenic liver abscess (PLA) is a purulent disease caused by microbial contamination of liver parenchyma and includes amoebic liver abscess, fungal liver abscess, and the most common bacterial liver abscess.
Explore the efficacy of contrast-enhanced ultrasound (CEUS) via vessels and surgical drain guidance percutaneous catheter drainage (PCD) in the treatment of pyogenic liver abscesses (PLA).
A total of 86 PLA patients who underwent PCD treatment in our hospital from May 2018 to February 2023 were retrospectively selected. Of them, 41 patients were treated under intravenous CEUS guidance (Control group), and 45 patients were treated under CEUS via vessels and surgical drain guidance (study group). Perioperative characteristics, treatment effectiveness, and incidence of complications were analyzed and compared between groups.
The duration of surgery, drainage, white blood cell recovery, body temperature recovery, and hospitalization in the study group were longer than those in the control group (P<0.05). The total effective rate of the study group (95.56%) was higher than that of the control group (80.49%) (P<0.05). The incidence of complications in the study group (4.44%) was lower than that in the control group (19.51%) (P<0.05).
Compared with intravenous CEUS alone, treatment under CEUS via vessels and surgical drains-guided PCD was associated with shorter surgical time, faster recovery, better treatment effect, lower risk of complications, and ensured treatment safety in PLA patients.
化脓性肝脓肿(PLA)是一种由肝实质微生物污染引起的化脓性疾病,包括阿米巴肝脓肿、真菌性肝脓肿以及最常见的细菌性肝脓肿。
探讨血管内及手术引流引导下的对比增强超声(CEUS)经皮导管引流(PCD)治疗化脓性肝脓肿(PLA)的疗效。
回顾性选取2018年5月至2023年2月在我院接受PCD治疗的86例PLA患者。其中,41例患者在静脉CEUS引导下接受治疗(对照组),45例患者在血管内及手术引流引导下的CEUS治疗(研究组)。分析比较两组患者的围手术期特征、治疗效果及并发症发生率。
研究组的手术时间、引流时间、白细胞恢复时间、体温恢复时间及住院时间均长于对照组(P<0.05)。研究组的总有效率(95.56%)高于对照组(80.49%)(P<0.05)。研究组的并发症发生率(4.44%)低于对照组(19.51%)(P<0.05)。
与单纯静脉CEUS相比,血管内及手术引流引导下的CEUS经皮导管引流治疗PLA患者,手术时间更短,恢复更快,治疗效果更好,并发症风险更低,确保了治疗安全性。